Guard Therapeutics International AB (publ) logo

Guard Therapeutics International AB (publ)

SSE:GUARD.ST

Overview | Financials
Company Name Guard Therapeutics International AB (publ)
Symbol GUARD.ST
Currency SEK
Price 19.8
Market Cap 199,219,680
Dividend Yield 0%
52-week-range 5.1 - 62.5
Industry Biotechnology
Sector Healthcare
CEO Mr. Tobias Larsson Agervald
Website https://guardtherapeutics.com

An error occurred while fetching data.

About Guard Therapeutics International AB (publ)

Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known

Related Stocks

Kancera AB (publ) logo

Kancera AB (publ)

KAN.ST

4.095 SEK

Alligator Bioscience AB (publ) logo

Alligator Bioscience AB (publ)

ATORX.ST

1.178 SEK

I-Tech AB logo

I-Tech AB

ITECH.ST

39.7 SEK

Initiator Pharma A/S logo

Initiator Pharma A/S

INIT.ST

8.08 SEK

OssDsign AB (publ) logo

OssDsign AB (publ)

OSSD.ST

8.8 SEK

Dignitana AB (publ) logo

Dignitana AB (publ)

DIGN.ST

1.94 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD